CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 15 enrolled
Drug / intervention
HYBENX®device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03060486
NCT03060486N/ACompleted
CompareCT.gov

A New Approach for Controlling Hemostasis During Canal Treatment: a Pilot Study

Dr Riccardo Pace·interventional·Posted Feb 23, 2017·Updated Oct 17, 2018

In Brief

A clinical study evaluating HYBENX® for Blood Contamination of Root Canal During Endodontic Therapy. Completed, enrolled 15 participants.

Detailed Summary

Blood contamination, such as apical microleakage, of root canal during preparation can be a major problem in endodontics. The purpose of this investigation was to evaluate the hemostatic properties of sulfonic/sulfuric acid solution used during root canal therapy in teeth with irreversible pulpitis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBlood Contamination of Root Canal During Endodontic Therapy
Countries--
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedFeb 23, 2017
Enrollment StartDec 1, 2016
Primary CompletionJan 10, 2017
Study CompletionJan 17, 2017
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 9.4 years ago

Interventions

HYBENX®device

The mixture was then introduced inside the root canal using the pre-dosed syringe for 20 seconds with a sterile paper point with and up and down movement. Finally, the canal was rinsed with sterile saline water using a syringe with a side-vented 30 G needle.